342 related articles for article (PubMed ID: 9570530)
41. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
42. Disruption of CD154:CD40 blocks generation of allograft immunity without affecting APC activation.
Shepherd DM; Kerkvliet NI
J Immunol; 1999 Sep; 163(5):2470-7. PubMed ID: 10452982
[TBL] [Abstract][Full Text] [Related]
43. Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4.
Macaulay AE; DeKruyff RH; Goodnow CC; Umetsu DT
J Immunol; 1997 May; 158(9):4171-9. PubMed ID: 9126977
[TBL] [Abstract][Full Text] [Related]
44. CD40 expressed on thymic epithelial cells provides costimulation for proliferation but not for apoptosis of human thymocytes.
Ruggiero G; Martinez Cáceres E; Voordouw A; Noteboom E; Graf D; Kroczek RA; Spits H
J Immunol; 1996 May; 156(10):3737-46. PubMed ID: 8621909
[TBL] [Abstract][Full Text] [Related]
45. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
46. The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration.
Nishioka Y; Lipsky PE
J Immunol; 1994 Aug; 153(3):1027-36. PubMed ID: 7517971
[TBL] [Abstract][Full Text] [Related]
47. Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells.
O'Regan AW; Hayden JM; Berman JS
J Leukoc Biol; 2000 Oct; 68(4):495-502. PubMed ID: 11037970
[TBL] [Abstract][Full Text] [Related]
48. T-cell-dependent antitumor effects produced by CD40 ligand expressed on mouse lung carcinoma cells are linked with the maturation of dendritic cells and secretion of a variety of cytokines.
Tada Y; O-Wang J; Yu L; Shimozato O; Wang YQ; Takiguchi Y; Tatsumi K; Kuriyama T; Takenaga K; Sakiyama S; Tagawa M
Cancer Gene Ther; 2003 Jun; 10(6):451-6. PubMed ID: 12768190
[TBL] [Abstract][Full Text] [Related]
49. Induction and inhibition of CD40-CD40 ligand interactions: a new strategy underlying host-virus relationships.
Sharma MD; Leite de Moraes M; Zavala F; Pontoux C; Papiernik M
J Immunol; 1998 Nov; 161(10):5357-65. PubMed ID: 9820509
[TBL] [Abstract][Full Text] [Related]
50. CD40L is important for induction of, but not response to, costimulatory activity. ICAM-1 as the second costimulatory molecule rapidly up-regulated by CD40L.
Shinde S; Wu Y; Guo Y; Niu Q; Xu J; Grewal IS; Flavell R; Liu Y
J Immunol; 1996 Oct; 157(7):2764-8. PubMed ID: 8816378
[TBL] [Abstract][Full Text] [Related]
51. Activated B cells express CD28/B7-independent costimulatory activity.
Ding L; Shevach EM
J Immunol; 1996 Aug; 157(4):1389-96. PubMed ID: 8759718
[TBL] [Abstract][Full Text] [Related]
52. Endothelial cells augment the expression of CD40 ligand on newly activated human CD4+ T cells through a CD2/LFA-3 signaling pathway.
Karmann K; Hughes CC; Fanslow WC; Pober JS
Eur J Immunol; 1996 Mar; 26(3):610-7. PubMed ID: 8605928
[TBL] [Abstract][Full Text] [Related]
53. Autogeneic rna-electroporated CD40-ligand activated b-cells from hepatocellular carcinoma patients induce CD8+ T-cell responses ex vivo.
Shen S; Xu Z; Qian X; Ding Y; Yu L; Liu B
Exp Oncol; 2007 Jun; 29(2):137-43. PubMed ID: 17704747
[TBL] [Abstract][Full Text] [Related]
54. Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis.
Wagner DH; Stout RD; Suttles J
Eur J Immunol; 1994 Dec; 24(12):3148-54. PubMed ID: 7528671
[TBL] [Abstract][Full Text] [Related]
55. Increased expression of CD40 ligand in activated CD4+ T lymphocytes of systemic sclerosis patients.
Valentini G; Romano MF; Naclerio C; Bisogni R; Lamberti A; Turco MC; Venuta S
J Autoimmun; 2000 Aug; 15(1):61-6. PubMed ID: 10936029
[TBL] [Abstract][Full Text] [Related]
56. B7/CD28-dependent and -independent induction of CD40 ligand expression.
Ding L; Green JM; Thompson CB; Shevach EM
J Immunol; 1995 Dec; 155(11):5124-32. PubMed ID: 7594521
[TBL] [Abstract][Full Text] [Related]
57. Cognate T cell help for CD40-deficient B cells induces c-myc RNA expression, but DNA synthesis requires an additional signal through surface Ig.
Schrader CE; Stavnezer J; Kikutani H; Parker DC
J Immunol; 1997 Jan; 158(1):153-62. PubMed ID: 8977186
[TBL] [Abstract][Full Text] [Related]
58. Ligation of CD28 in vivo induces CD40 ligand expression and promotes B cell survival.
Yin D; Zhang L; Wang R; Radvanyi L; Haudenschild C; Fang Q; Kehry MR; Shi Y
J Immunol; 1999 Oct; 163(8):4328-34. PubMed ID: 10510372
[TBL] [Abstract][Full Text] [Related]
59. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production.
Yoshimoto T; Takeda K; Tanaka T; Ohkusu K; Kashiwamura S; Okamura H; Akira S; Nakanishi K
J Immunol; 1998 Oct; 161(7):3400-7. PubMed ID: 9759857
[TBL] [Abstract][Full Text] [Related]
60. Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo.
Borges L; Miller RE; Jones J; Ariail K; Whitmore J; Fanslow W; Lynch DH
J Immunol; 1999 Aug; 163(3):1289-97. PubMed ID: 10415026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
